API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
64
PharmaCompass offers a list of 4-Aminobenzoic Acid API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right 4-Aminobenzoic Acid manufacturer or 4-Aminobenzoic Acid supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred 4-Aminobenzoic Acid manufacturer or 4-Aminobenzoic Acid supplier.
PharmaCompass also assists you with knowing the 4-Aminobenzoic Acid API Price utilized in the formulation of products. 4-Aminobenzoic Acid API Price is not always fixed or binding as the 4-Aminobenzoic Acid Price is obtained through a variety of data sources. The 4-Aminobenzoic Acid Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 06940_FLUKA manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 06940_FLUKA, including repackagers and relabelers. The FDA regulates 06940_FLUKA manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 06940_FLUKA API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A 06940_FLUKA supplier is an individual or a company that provides 06940_FLUKA active pharmaceutical ingredient (API) or 06940_FLUKA finished formulations upon request. The 06940_FLUKA suppliers may include 06940_FLUKA API manufacturers, exporters, distributors and traders.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing 06940_FLUKA as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for 06940_FLUKA API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture 06940_FLUKA as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain 06940_FLUKA and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a 06940_FLUKA NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of 06940_FLUKA suppliers with NDC on PharmaCompass.
06940_FLUKA Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 06940_FLUKA GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 06940_FLUKA GMP manufacturer or 06940_FLUKA GMP API supplier for your needs.
A 06940_FLUKA CoA (Certificate of Analysis) is a formal document that attests to 06940_FLUKA's compliance with 06940_FLUKA specifications and serves as a tool for batch-level quality control.
06940_FLUKA CoA mostly includes findings from lab analyses of a specific batch. For each 06940_FLUKA CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
06940_FLUKA may be tested according to a variety of international standards, such as European Pharmacopoeia (06940_FLUKA EP), 06940_FLUKA JP (Japanese Pharmacopeia) and the US Pharmacopoeia (06940_FLUKA USP).